www.cancerindetail.com

Pick your poison

2 hrs ago | foxnews.com

I have knocked down two of the four chemotherapy treatments I need to complete in the month of May. Today will be chemo #3, and after next week (chemo #4), we will scan my liver and see where we stand Read more...

Noreen Fraser Noreen chemo poison cancer pick Fraser 12-week morphine metastatic chemos January-February-March chemotherapy pain liver tumor STAND UP

Positive Phase 2 Clinical Data With Tivantinib in Hepatocellular Carcinoma to be Highlighted in...

4 hrs ago | premiumpresse.de

Woburn, Massachusetts And Tokyo (otsPRNewswire) - ArQule, Inc. and Daiichi Sankyo, Co., Ltd. (TSE 4568) todayannounced that an oral presentation at the Annual Meeting of theAmerican Society of Clinical Oncology (ASCO) will... Read more...

tivantinib ArQule Sankyo Poster Daiichi ARQ c-MET HCC trial Phase clinical

image

InPlay: Wal-Mart beats by $0.05, beats on revs, U.S. Q1 comps +2.6% and Sam's Q1 comps +5.3%;...

5 hrs ago | finance.yahoo.com

TASER International (TASR) received an order from the Ohio State Highway Patrol Academy for 485 TASER X26 ECDs. Also, co received a second order from from the Austin Police Department for 100 TASER X26 ECDs with extended... Read more...

rev Estimate Consensus IQ mln Q1 FY13 Co bln comps Capital EPS in-line Q2 guidance GasLog ScreenCell $0.03 $0.05 beat CoreValve

SILENCE THERAPEUTICS PLC - New data from Phase I trial with Atu027

11 hrs ago | finanznachrichten.de

SILENCE THERAPEUTICS PLC - New data from Phase I trial with Atu027 FOR IMMEDIATE RELEASE Atu027, a First in Class RNAi Therapy, Demonstrates Potential Antitumour Activity in Cancer Patients and Possible Biomarker Identified... Read more...

Atu027 siRNA Phase silence RNAi therapeutics plc PKN3

Transgene Announces Presentations Relating to TG4010 and JX594/TG6006 at Annual Meeting of the...

11 hrs ago | euronext.com

Regulatory News: Transgene (Paris:TNG) (Euronext Paris: FR0005175080) today announces that four separate abstracts relating to clinical studies of the therapeutic cancer vaccine TG4010 and the oncolytic virus JX594/TG6006 have... Read more...

TG4010 Transgene TG6006 JX594 cancer JX-594 phase

New Data from Bristol-Myers Squibb Oncology Portfolio to be Presented at 2012 American Society of...

19 hrs ago | finanznachrichten.de

Ten Oral Presentations Underscore Breadth and Diversity of Company's Oncology Portfolio New Data on YERVOY® (ipilimumab) and the Investigational Compounds Anti-PD-1 (BMS-936558) and Elotuzumab Reinforce Company's Leadership in... Read more...

YERVOY Bristol-Myers Squibb immune-mediated metastatic melanoma ERBITUX Oncology elotuzumab SPRYCEL Presented treatment Data CML cancer patient BMS-936558 Portfolio endocrinopathy investigational Phase ASCO study reaction myeloma

Transarterial Embolization With Cyanoacrylate for Severe Arterioportal Shunt Complicated by...

21 hrs ago | springerlink.com

Conclusion The preliminary experience suggests that glue embolization may be an effective and safe therapy in the management of severe APS accompanied by HCC and also improve patient survival. Content Type Journal... Read more...

Hai-Bin Shi Transarterial APS shunt Emb non-Emb embolization HCC severe hepatofugal chemoperfusion patient glue cyanoacrylate survival

Featured Clinical Trial: Experimental Antibody for Treatment-Resistant Liver Cancer

May 16, 2012 | cancer.gov

Experimental Antibody for Treatment-Resistant Liver Cancer Name of the Trial TRC 105 for Liver Cancer that Has Not Responded to Sorafenib (NCI-11-C-0181). See the protocol summary . Principal Investigator Dr. Tim Greten, NCI... Read more...

Treatment-Resistant liver cancer hepatocellular experimental carcinoma trial NCI-11-C-0181 patient

image

MultiCell Technologies Announces Positive Preclinical Results for MCT-465 and MCT-485 in Primary...

May 16, 2012 | finanznachrichten.de

WOONSOCKET, R.I., May 16, 2012 /PRNewswire/ --MultiCell Technologies, Inc. (OTC Bulletin Board: MCET) is pleased to announce representatives from the Company will present preclinical research findings for MCT-465 and MCT-485 at... Read more...

MultiCell MCT-465 MCT-485 immune cell cancer tumor TLR3 MDA-5

Baking soda, cancer and fungus

May 16, 2012 | newstarget.com

The cancer industry is closing in on baking soda and beginning to do research in earnest about sodium bicarbonate and how it is a primary tool in the treatment of fungus. Cancer is a fungus, can be caused by a fungus, or is... Read more...

fungus cancer fungal infection Sircus spp soda tissue baking aflatoxin sodium bicarbonate patient tumor

IJMS, Vol. 13, Pages 5571-5583: Effect of Tea Polyphenol on Oxidative Injury in S180 Cells...

May 16, 2012 | chemie.de

The purpose of this study was to evaluate the antioxidant nature of tea polyphenol on S180 cells induced liver cancer in mice. In the present study, hepatocellular carcinoma was induced by tumor transplantation of liver in... Read more...

S180 tea polyphenol cell serum antioxidant effect hepatocellular induce liver Qi-Bo aminotransfere Bo-Kang MDA

Just Released: "Sirtex Medical Limited (SRX) - Financial and Strategic SWOT Analysis Review"

May 16, 2012 | nucleonica.net

Sirtex Medical Limited (Sirtex), a biotechnology and medical device company is engaged in the developing, manufacturing and marketing of selective internal radiation therapies (SIRT) in the area of liver cancer. Its principal... Read more...
All similar articles: 443 >>

Sirtex GlobalData SRX analysis key financial profile swot Medical Pty

Expression and Functional Coupling of Liver β2-Adrenoceptors in the Human Hepatocellular Carcinoma

May 15, 2012 | karger.com

Woubet T. Kassahuna, Bianca Guenla, Fritz R. Ungemachb, Sven Jonasa, Getu Abrahamb aDepartment of Surgery II, Faculty of Medicine, and bInstitute of Pharmacology, Pharmacy and Toxicology, University of Leipzig, Leipzig, Germany... Read more...

β2 HCC Hepatocellular AR β expression receptor Gsα postreceptor density liver ARs protein membrane

The Alert Competition Room - rules on first post

May 15, 2012 | hotstockmarket.com

› The Alert Competition Room - rules on first post I've been trading with them for two weeks and everything has gone smoothly. Edit: Dec 5 On Dec 2 they experienced system problems and I have been unable to place any trades.... Read more...

liver MultiCell Alert Competition afford Room 7935528 Newmin Technologies stem cell disease risk UNDT location post chart never lose rule USPTO

Galectin Therapeutics Announces Initiation of Phase 1/2 Trial of Novel Combination Therapy for...

May 15, 2012 | fortmilltimes.com

Galectin Therapeutics (NASDAQ: GALT) (“the Company”), the leader in developing carbohydrate-based therapeutic compounds to inhibit galectin proteins for the therapy of liver fibrosis and cancer, today announced that the first... Read more...

Galectin GM-CT-01 patient Therapeutics metastatic trial initiation peptide therapy universitaires Cliniques Saint-Luc vaccination carbohydrate-based peri-tumoral melanoma NA17.A2 vaccine Baurain combination novel

Celsion Reports First Quarter 2012 Financial Results

May 15, 2012 | premiumpresse.de

LAWRENCEVILLE, NJ -- (Marketwire) -- 051512 -- Celsion Corporation (NASDAQ: CLSN), a leading oncology drug development company, today announced financial results for the first quarter ended March 31, 2012 and provided a... Read more...

ThermoDoxreg Celsion HEAT Study Companys liver Phase RFA cancer

HIV–HBV Coinfection — A Global Challenge

May 15, 2012 | intute.ac.uk

Athena P. Kourtis, M.D., Ph.D., M.P.H., Marc Bulterys, M.D., Ph.D., Dale J. Hu, M.D., M.P.H., and Denise J. Jamieson, M.D., M.P.H. Human immunodeficiency virus type 1 (HIV-1) and hepatitis B virus (HBV) exact a high toll... Read more...

Athena P. Kourtis HBV HIV hepatitis coinfection coinfected perinatal HIV-infected

4SC AG (DE0005753818) : DGAP-News: Press Release 4SC AG: 4SC's partner Yakult Honsha starts...

May 15, 2012 | investir.fr

DGAP-News: 4SC AG / Key word(s): Miscellaneous Press Release 4SC AG: 4SC's partner Yakult Honsha starts clinical development with cancer compound resminostat in Japan Press Release 4SC's partner Yakult Honsha starts clinical... Read more...

4SC resminostat Yakult Honsha HCC AG DE0005753818 cancer clinical

Scientists make breakthrough in bile duct cancer with discovery of new gene mutations

May 14, 2012 | eurekalert.org

A team of international scientists has made a significant breakthrough in understanding the cause of bile duct cancer, a deadly type of liver cancer. By identifying several new genes frequently mutated in bile duct cancers,... Read more...

bile duct cancer Duke-NUS Singapore gene NCCS Cholangiocarcinoma Thailand Kaen Khon liver mutation Research scientist Andel Teh discovery breakthrough

BioAlliance Pharma SA:Initiation of ReLive, phase III clinical trial with Livatag® In primary...

May 14, 2012 | euronext.com

Regulatory News: BioAlliance Pharma SA (Euronext Paris:BIO), a Company dedicated to orphan oncology products and specialty products, today announces the initiation of ReLive, its phase III clinical trial with Livatag®... Read more...

BioAlliance Livatag ReLive Pharma phase clinical trial III SA

LILLY (ELI) & COMPANY - ASCO Pipeline Media Alert

May 14, 2012 | finanznachrichten.de

Issue Date: May 14, 2012 Media Alert Media Contacts: LILLY ONCOLOGY TO DISCLOSE NEW PIPELINE DATA AT ASCO 2012 Updates on Three of Six Ongoing Phase III Ramucirumab Trialsto Be Presented INDIANAPOLIS, May 14, 2012 - Eli Lilly... Read more...

Lilly ramucirumab ASCO LY900009 LY2228820 oral IMC-1121B inhibitor pipeline first-in-human cancer patient Phase poster III abstract dimesylate

A mother's hunch may have saved her baby's life

May 13, 2012 | gannett-tv.com

HOUSTON - Mother's Day celebrates that special bond between a mother and her child. Part of that bond is what is known as a mother's intuition, and one mom is grateful that she trusted hers. She will be celebrating her first... Read more...

Ava tumor Browning mother baby save chemo intuition life birth pediatric hepatoblastoma blastoma newborn liver child

Chesapeake Relay for Life offers cancer research possibilities

May 13, 2012 | hamptonroads.com

greenbrier Damion Kelly still has the scar. The 5-year-old from Virginia Beach was 7 months old when he was diagnosed with neuroblastoma and had to have a malignant tumor removed from nerve tissue in the right side of his back.... Read more...

Lydia Wheeler Chesapeake Relay cancer Klatt Life Carlile Hastings Damion Linda Curt

At the same time, the enumerated below concepts

May 12, 2012 | edurneweb.com

At the same time, the enumerated below concepts are very important both for communities: always make sure appropriate all-around routine and in addition sanitation, a good availabilit of good water supply, and therefore highly... Read more...

enumerated intestinal furazolidone concept fitflop cholera malabsorption biliary tract antibiotic tetracycline colic treatment below insufficiency sickness.Pancreatic syndrome.Bile sameCheap syndromeMaldigestion the.delaware sprue.Alternative Youths.Commercial cirrhosis colitis care.Lee Heels

11.[27-30]Hepatoid Adenocarcinoma of the Stomach - Copy

May 10, 2012 | docstoc.com

International Journals Call for paper, http://www.iiste.org Journal of Biology, Agriculture and Healthcare www.iiste.org Hepatoid Adenocarcinoma of the Stomach – a rare histology of Gastric Adenocarcinoma in an adolescent: a... Read more...

Hepatoid adenocarcinoma stomach carcinoma www.iiste.org hepatocellular

One in six cancers the result of infection, study suggests

May 10, 2012 | catholic.org

More efforts are needed to recognize cancer as a communicable disease One in six cancers, or two million cases a year globally are caused by largely treatable or preventable infections, a new study suggests. According to the... Read more...

cancer infection infection-related U.K. HPV preventable case vaccination pylori suggest study liver vaccine

4SC AG (DE0005753818) : DGAP-News: Press Release 4SC AG: 4SC Announces Financial Results for the...

May 10, 2012 | investir.fr

DGAP-News: 4SC AG / Key word(s): Quarter Results/Miscellaneous Press Release 4SC AG: 4SC Announces Financial Results for the First Quarter of 2012 Press Release 4SC Announces Financial Results for the First Quarter of 2012... Read more...

4SC resminostat AG 2012 DGAP-News vidofludimus

IBN's Droplet Array Sheds Light On Drug-Resistant Cancer Stem Cells

May 9, 2012 | comparenetworks.com

Researchers at the Institute of Bioengineering and Nanotechnology (IBN), the world's first bioengineering and nanotechnology research institute, have developed a miniaturized biochip for investigating the effect of drugs on... Read more...

CSCs IBN Droplet cell Array cancer drug tumor stem

Kept in the dark

May 9, 2012 | jimbocyberdoc.wordpress.com

This morning, during the ward round, the daughter-in-law of a man repeated implored me to not tell the latter that he has hepatocellular carcinoma which has spread to his spine. He was admitted for progressively enlarging... Read more...

DIL diagnosis patient dark doctor conspiracy daughter-in-law father-in-law prognosis abdomen pussy-footed faith-healer liver condition fluid cure terminal

CBC Canadian News: Cancer death rates show decline

May 9, 2012 | cbc.ca

Death rates for the four major cancers — lung, colorectal, breast and prostate — are declining, thanks to falling smoking rates and increases in screening and treatment, the Canadian Cancer Society says. Read more...
All similar articles: 140 >>

cancer death rate decline colorectal Canadian incidence smoking lung thyroid breast liver

image